Allison Freeman

1.3k total citations
9 papers, 905 citations indexed

About

Allison Freeman is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Allison Freeman has authored 9 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Orthopedics and Sports Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Allison Freeman's work include Bone health and osteoporosis research (4 papers), Adrenal Hormones and Disorders (3 papers) and Blood Pressure and Hypertension Studies (2 papers). Allison Freeman is often cited by papers focused on Bone health and osteoporosis research (4 papers), Adrenal Hormones and Disorders (3 papers) and Blood Pressure and Hypertension Studies (2 papers). Allison Freeman collaborates with scholars based in United States, Spain and Netherlands. Allison Freeman's co-authors include Jeroan J. Allison, Andrew O. Westfall, Claire M. Spettell, Jeffrey R. Curtis, Kenneth G. Saag, Stacey H. Kovac, Varghese George, J. W. J. Bijlsma, Renée J.G. Arnold and Sameer Bansilal and has published in prestigious journals such as Journal of the American College of Cardiology, Osteoporosis International and Pharmacoepidemiology and Drug Safety.

In The Last Decade

Allison Freeman

9 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison Freeman United States 8 205 165 142 131 130 9 905
Masayo Sato Japan 17 162 0.8× 58 0.4× 102 0.7× 50 0.4× 24 0.2× 70 958
Kathleen A. Foley United States 15 147 0.7× 72 0.4× 161 1.1× 44 0.3× 31 0.2× 33 969
Ashley L. Cole United States 18 36 0.2× 83 0.5× 82 0.6× 42 0.3× 41 0.3× 52 1.1k
Alan Bell Canada 14 199 1.0× 78 0.5× 208 1.5× 342 2.6× 9 0.1× 53 997
Kavita Nair United States 18 18 0.1× 54 0.3× 153 1.1× 153 1.2× 157 1.2× 65 1.3k
Raquel Lahoz Switzerland 19 25 0.1× 67 0.4× 92 0.6× 307 2.3× 38 0.3× 53 859
Richard E. Scranton United States 20 38 0.2× 390 2.4× 72 0.5× 158 1.2× 19 0.1× 48 1.4k
Hajime Orimo Japan 14 275 1.3× 130 0.8× 139 1.0× 83 0.6× 8 0.1× 62 848
Michael K. Davies United Kingdom 14 184 0.9× 45 0.3× 111 0.8× 451 3.4× 11 0.1× 38 852
Jason Yeaw United States 12 21 0.1× 217 1.3× 35 0.2× 71 0.5× 225 1.7× 37 847

Countries citing papers authored by Allison Freeman

Since Specialization
Citations

This map shows the geographic impact of Allison Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Freeman more than expected).

Fields of papers citing papers by Allison Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Freeman. The network helps show where Allison Freeman may publish in the future.

Co-authorship network of co-authors of Allison Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Freeman. A scholar is included among the top collaborators of Allison Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Freeman. Allison Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Spettell, Claire M., et al.. (2019). Aetna's Compassionate Care Program: Sustained Value for Our Members with Advanced Illness. Journal of Palliative Medicine. 22(11). 1324–1330. 7 indexed citations
2.
Freeman, Allison, et al.. (2018). Drug-induced eosinophilia. Allergy and Asthma Proceedings. 39(3). 252–256. 7 indexed citations
3.
Bansilal, Sameer, José M. Castellano, Henry Wei, et al.. (2016). Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes. Journal of the American College of Cardiology. 68(8). 789–801. 192 indexed citations
4.
Bansilal, Sameer, Henry Wei, José M. Castellano, et al.. (2015). ASSESSING THE IMPACT OF MEDICATION ADHERENCE ON LONG-TERM OUTCOMES IN PATIENTS WITH DIABETES. Journal of the American College of Cardiology. 65(10). A1409–A1409. 1 indexed citations
5.
Curtis, Jeffrey R., Andrew O. Westfall, Jeroan J. Allison, et al.. (2007). Challenges in Improving the Quality of Osteoporosis Care for Long-term Glucocorticoid Users. Archives of Internal Medicine. 167(6). 591–591. 70 indexed citations
6.
Curtis, Jeffrey R., Andrew O. Westfall, Jeroan J. Allison, et al.. (2006). Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiology and Drug Safety. 15(10). 710–718. 55 indexed citations
7.
Curtis, Jeffrey R., Andrew O. Westfall, Jeroan J. Allison, et al.. (2006). Population‐based assessment of adverse events associated with long‐term glucocorticoid use. Arthritis Care & Research. 55(3). 420–426. 418 indexed citations
8.
Curtis, J. Randall, et al.. (2006). Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. Osteoporosis International. 17(8). 1268–1274. 35 indexed citations
9.
Curtis, Jeffrey R., Andrew O. Westfall, Jeroan J. Allison, et al.. (2005). Longitudinal patterns in the prevention of osteoporosis in glucocorticoid‐treated patients. Arthritis & Rheumatism. 52(8). 2485–2494. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026